gliclazide has been researched along with Pleural Effusion in 1 studies
Gliclazide: An oral sulfonylurea hypoglycemic agent which stimulates insulin secretion.
Pleural Effusion: Presence of fluid in the pleural cavity resulting from excessive transudation or exudation from the pleural surfaces. It is a sign of disease and not a diagnosis in itself.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tzanakis, N | 1 |
| Bouros, D | 1 |
| Siafakas, N | 1 |
1 other study available for gliclazide and Pleural Effusion
| Article | Year |
|---|---|
Eosinophilic pleural effusion due to gliclazide.
Topics: Diabetes Mellitus, Type 2; Gliclazide; Humans; Hypoglycemic Agents; Male; Middle Aged; Pleural Effus | 2000 |